The world and the reality we live in has significanlty changed since COVID19 Lockdown started. We have learnt a lot about our resilience, ability to adapt, the state of our healthcare system, our economy and the government in the last ten weeks.
The tragedy that has unfolded on the poorest migrant labourers in India will be remembered for a long time to come. It will also shape a lot of our decisions and actions in the future including those that involve building healthcare capacity.
This article aims to explore the current status of the pandemic in India in relation to the rest of the world ever since the lockdown began. The analysis is effectively a continuation of the previous three articles that were written on the same subject.
The methodology applied and index of countries developed are the same with two new additions Brazil and the Russian Federation. The data of transmission and mortality was sourced from the World Health Organisation for a period starting from 1st of March till the 25th of May.
I will present this article through six figures that will allow the reader to understand the current circumstances and raising questions we are not considering yet.
The methodology applied and index of countries developed are the same with two new additions Brazil and the Russian Federation. The data of transmission and mortality was sourced from the World Health Organisation for a period starting from 1st of March till the 25th of May.
I will present this article through six figures that will allow the reader to understand the current circumstances and raising questions we are not considering yet.
Figure 1 - Global COVID19 cumulative infection cases and mortality
The global cumulative number of cases has grown to 5,304,772 ( 5.3 million or 53 lakh) and cumulative number of deaths from the infection have increased to 342,029. This corresponds to a global average transmission rate of 0.29 (also known as Ro). The global average mortality rate corresponds to 5.7%.
The transmission rate is essentially less than 1 which implies the transmission is decreasing even though the number of cumulative cases have been climbing. The slowdown globally is also marked by an increase in mortality rate along with the rise in cumulative cases. That remains a cause for concern though the mortality numbers do not differentiate co-morbidities or other secondary causes of death.
Figure 2- India COVID19 cumulative infection cases and mortality
During the same period of COVID19 infection growth in India the cumulative number climbed to 138, 845 (1.38 lakh). The mortality in the same duration was reported at 4,021. This corresponds to an average transmission rate (Ro) of 1.24 and an average mortality rate of 2.5%.
While the Global transmission rate is slowing down, the disease is still proliferating and spreading in India. It has slowed from the early days of infection spread. India is facing several challenges as we are just graduating from cluster of cases to community level transmission. The level of testing, identification and isolation of potential carriers of the corona virus in particular is a concern.
Figure 3 - Comparison of average transmission rate of nations with increasing proliferation (rate >1)
For the comparable nations index of transmission rate, six countries are still facing an increasing proliferation of the disease. These countries are Brazil (1.35), USA (1.29), India (1.24), Russia (1.23), Spain (1.1) and Germany (1.07). The corresponding cumulative infection number for Brazil is 347,398, USA at 1,592,599, Russia at 353,427, Spain at 2,35,772, Germany at 178,570. Brazil and Russia have recently witnessed an explosion of cases. India remains one of the top three nations for COVID19 disease proliferation in the world.
As it is evident from the figure above the average transmission rate has flattened significantly for all these nations. The average transmission rate for the last 35 days for these 6 countries is under 1, therefore implying a slow down of the disease proliferation. Even at a slowed down rate the disease is expected to spread due to the high cumulative number of infected patients and stage of pandemic reaching community transmission.
Figure 4- Comparison of average transmission rate of nations with decreasing proliferation (rate < 1)
The average transmission rate in comparable highly impacted nations index with a decreasing rate of proliferation is shown in the figure above. Essentially these are nations where the disease proliferation has slowed down significantly and new cases are fewer in number.
The average transmission rate for UK was 0.977, France at 0.758, Iran at 0.564, Italy at 0.483 and China at 0.033. It is notable to mention that all the countries in the Index have a higher transmission rate than the Global average 0.29.
The cumulative infection number for these comparable nations are UK at 259,563, France at 142,204, Iran at 135,701, Italy at 229,858 and China at 84,536 . China has shown the greatest resilience in slowing down the proliferation and reducing the cumulative infection numbers.
The average transmission rate for the last 45 days has been under 1, therefore the disease proliferation has effectively slowed down. For the last 30 days in particular the disease proliferation has significantly slowed down.
Even though the rate of transmission is very slow, the cumulative number of patients is significantly high. There is still a high risk of a second wave of infections. It is very encouraging to note that nations such as Italy and UK where the health system was overwhelmed two months ago have managed to stabilise.
Figure 5 - High average mortality rate in the comparable nations index
The high average mortality rate for comparable nations index is shown in the figure above. The nations with high mortality rate are France (12.71%), Italy (11.53%), UK (10.05%), Spain (8.79%) and Iran (5.95%). Their average rates are higher than the average Global mortality rate (5.73%). It is notable to mention that the average mortality rates are increasing for the past 35 days for Italy, France and Spain.
The corresponding cumulative death numbers are France at 28,315, Italy at 32,785, UK at 36,793, Spain at 28,752 and Iran at 7,417.
Figure 6- Lower average mortality rate in the comparable nations index
The low average mortality rate for comparable nations is shown in the figure above. The average mortality rate for China is 4.69%, Brazil at 4.5%, USA at 4.24%, India at 2.5%, Germany at 2.43% and Russia at 0.65%. All of these are notably below the average Global Mortality rate. Brazil and Germany have witnessed a gradual increase in average mortality rate. The average mortality rate for India is lower than most other nations in the index with the exception of Germany and Russia.
The cumulative deaths for comparable nations with lower average mortality rate are China 4,645, Brazil 22,013, USA 95,863, Germany 8,257 and Russia 3,633. USA is the most impacted in the shear number of deaths. India in comparison has lower cumulative mortality than all other nations except Russia.
While India may have escaped the worst in rapid proliferation early on in the pandemic, it is yet to face the worst that could overwhelm the healthcare system. We are still 8-10 weeks away from the point where the infection proliferation has dramatically slowed down and the daily increases are on the wane.
More cases are likely to show up in rural India than urban at this stage given the very large numbers for reverse migration of labour and the recent breakdown of social distancing norms during travel. Urban areas are likely to see an increase to due to the easing of lockdown, high density of population engagement and people becoming complacent about their own protection.
Given the head start, India must also prepare for the second wave of infections that is likely to rise in October or November this year. There is a degree of fatigue that our healthcare workers and administrative staff are facing. The system functionaries are likely to become careless given the stretch of our resources.
Wider participation of the private sector and NGOs for relief work should be carefully considered to augment government capacity. An increase in the budgeted amount for healthcare must be undertaken urgently to enable wider participation and deeper grass root reach of health interventions.
There are numerous lessons we can draw from standard operating procedures established by government and correct them based on feedback from the ground experience especially the ones dealing with the most vulnerable population.
Primary healthcare is an aspect of our government interventions that is woefully short on the desired outcome. We have not been able to reinforce them or strengthen where basics are still missing. Lack of intervention at the sub-centre level will lead to serious difficulty in the event of large proliferation in rural India especially citizens who are seriously mal-nourished and those with comorbidities.
We must radically increase the testing of the population by improving the presence of laboratories with COVID19 sample analysis capability at the district level. Effective contact tracing , isolation and treatment will only follow naturally. Strengthened laboratory systems will provide real time data and analytics for transmission and mortality surveillance system. Thereby decision making at district level and policy responses at head-quarters will also improve. At the moment these are serious gaps in our response that must be addressed at the earliest.
Finally, we must understand why are zoonotic viruses really impacting us at such an apocalyptic scale time and again. We have to rethink our economic models that rely on systematic destruction of natural habitats and bio diversity on the planet leading to unleashing of viruses with no human immunity. There is a known causal effect but we need to establish the correlation through rigorous research.
COVID19 is not about to disappear in the next few weeks or months. We have to establish systems to live with it until we can discover a cure or a vaccine. Even then viruses mutate and continue to haunt us. We must change our approach to healthcare, one that includes vulnerable communities, the planet and animal species. Our collective survival depends on our ability to transform at this precipice where we stand right now.
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------